Practitioner Resources

Practitioner Fasting Guide PDF
Download the fasting guide
Patient Brochure PDF
Download brochure
Fasting Mimicking Diet and Diabetes
Diabetic kidney disease is the leading cause of end-stage kidney complication in people with diabetes. Investigators from the Heidelberg University Hospital in Germany published a study in the Journal of Clinical Endocrinology & Metabolism showing that the fasting mimicking diet...
ProLon improves healthy skin
We have heard anecdotes about ProLon improving the skin. Now we have the science to back it up. The study suggests that fasting impacts every cell in the body including our skin. The effects of the fasting-mimicking diet on facial...
Fast Bar to support Time Restricted Eating (16:8 diet)
Fast Bar is similar to the L-Bar found in ProLon. It has been shown not to break the overnight fast when eaten in the morning. This may be helpful for people who want to practice a long overnight fast (time...
Fasting and Metabolic Syndrome
A systemic review and meta-analysis of randomised controlled trials found that intermittent fasting (alternate day fasting, TRF, periodic fasting, religious fasting) were associated with an improvement in cardiometabolic risk factors, including weight, waist circumference, fat mass, BMI, blood pressure, total...
Fasting for Weight Loss
Low Carb versus Balanced Carbs: Same effect Debates on effective and safe diets for managing obesity and type 2 diabetes in adults are ongoing. Low-carbs diets are widely promoted as being more effective for weight loss than other diets. A...
Fasting, Autophagy and Neurodegenerative Diseases
Increasing evidence suggests that dysregulation of autophagy results in the accumulation of abnormal proteins and/or damaged organelles, which is commonly observed in neurodegenerative diseases, such as Alzheimer, Huntington’s, and Parkinson’s diseases  (Banerjee, Beal, and Thomas 2010). Impaired protein homeostasis and...
Long COVID and Fasting
Undertaking the ProLon Fasting Mimicking Diet (FMD) during COVID has not been tested so we have no data and can therefore not recommend ProLon during an active case of COVID. Likewise, we have no data guiding a decision to abort...
Fasting and Long COVID
Undertaking the ProLon Fasting Mimicking Diet (FMD) during COVID has not been tested so we have no data and can therefore not recommend ProLon during an active case of COVID. Likewise, we have no data guiding a decision to abort...
Day 6 Transition Diet
Download the handout: Day 6 Transition Diet
Starvation, detoxification, and multi-drug resistance in cancer therapy.
The selection of chemotherapy drugs is based on the cytotoxicity to specific tumour cell types and the relatively low toxicity to normal cells and tissues. However, the toxicity to normal cells poses a major clinical challenge, particularly when malignant cells...
Dietary Interventions, Cardiovascular Ageing, and Disease Animal Models and Human Studies
Recent studies indicate that dietary interventions have the potential to prevent and even treat cardiovascular disease, which is the leading cause of death. Many of these studies have focused on various animal models that are able to recreate one or...
Protein restriction cycles reduce IGF-1 and phosphorylated Tau, and improve behavioural performance in an Alzheimer’s disease mouse model
In laboratory animals, calorie restriction (CR) protects against ageing, oxidative stress, and neurodegenerative pathologies. Reduced levels of growth hormone and IGF-1, which mediate some of the protective effects of CR, can also extend longevity and/or protect against age-related diseases in...
Short-term calorie and protein restriction provide partial protection from chemotoxicity but do not delay glioma progression
short-term starvation (STS) protects normal cells while simultaneously sensitising malignant cells to high-dose chemotherapeutic drugs in mice and possibly patients. The fasting-dependent protection of normal cells and sensitisation of malignant cells depends, in part, on reduced levels of insulin-like growth...
Fasting enhances the response of glioma to chemo and radiotherapy
Glioma, including anaplastic astrocytoma and glioblastoma multiform (GBM) are among the most commonly diagnosed malignant adult brain tumours. GBM is a highly invasive and angiogenic tumour, resulting in a 12 to 15 months median survival. The treatment of GBM is...